NuVasive (NUVA +7.2%) shares are upgraded to Outperform by JMP Securities on signs that the...
NuVasive (NUVA +7.2%) shares are upgraded to Outperform by JMP Securities on signs that the fundamentals of the slumping market for spine products have turned a corner. The firm says NUVA is well positioned to benefit from what should prove a long-term trend because of its focus on minimally invasive surgery and its acquisition of Impulse Monitoring.
From other sites
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
at CNBC.com (Jun 28, 2012)
at CNBC.com (Jun 23, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs